Crow Point Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$380K Buy
4,403
+511
+13% +$44.7K 0.59% 37
2019
Q3
$331K Sell
3,892
-585
-13% -$52.1K 0.05% 84
2019
Q2
$471K Buy
4,477
+163
+4% +$16.4K 0.08% 65
2019
Q1
$456K Hold
4,314
0.08% 62
2018
Q4
$354K Buy
4,314
+422
+11% +$38.2K 0.07% 72
2018
Q3
$397K Buy
3,892
+1,296
+50% +$125K 0.07% 93
2018
Q2
$211K Buy
+2,596
New +$206K 0.04% 109

Other funds holding NGVT

Crow Point Partners's NGVT Position: Q4 2019 in Review

Crow Point Partners increased its Ingevity (NGVT) stake by 13% in Q4 2019, buying an estimated $44.7K and bringing the position to 4,403 shares worth $380K. The position accounts for 0.59% of the portfolio, ranked #37.

Crow Point Partners first reported a position in NGVT in Q2 2018 and has held it in 7 quarters since. The position peaked at $471K in Q2 2019. 334 funds tracked by Wall St. Rank hold NGVT as of Q4 2019.

  • Crow Point Partners held 4,403 shares of Ingevity worth $380K as of Q4 2019.
  • Crow Point Partners bought 511 Ingevity shares in Q4 2019, an estimated $44.7K.
  • Ingevity made up 0.59% of Crow Point Partners's portfolio in Q4 2019, its #37 holding.
  • Crow Point Partners first reported a position in Ingevity in Q2 2018 and has held it in 7 quarters since.
  • Crow Point Partners's Ingevity position peaked at $471K in Q2 2019.
  • 334 funds tracked by Wall St. Rank held Ingevity as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.